Skip to main content
. 2006 Apr 19;2006(2):CD005321. doi: 10.1002/14651858.CD005321.pub2

Comparison 19. Hyalgan versus Hyalgan.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Patient global (number of patients assessing response as satisfactory) 1   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.1 45 to 52 weeks post‐injection 1 159 Risk Ratio (M‐H, Fixed, 95% CI) 0.85 [0.70, 1.03]